BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion. 1995;35:5-12. [PMID: 7998069 DOI: 10.1046/j.1537-2995.1995.35195090661.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18:55-61. [PMID: 18279193 DOI: 10.1111/j.1365-3148.2007.00806.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
2 Allain J. Occult hepatitis B virus infection. Transfusion Clinique et Biologique 2004;11:18-25. [DOI: 10.1016/j.tracli.2003.11.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
3 Vermeulen M, Lelie N, Reddy R. Recent insights in testing for transfusion transmissible viral infections: Insights in transfusion testing. ISBT Science Series 2011;6:229-33. [DOI: 10.1111/j.1751-2824.2011.01492.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007;40:255-8. [PMID: 17869170 DOI: 10.1016/j.jcv.2007.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R, Zhu H, He Y, Li J, Huang H, Li W, Zhang K, Zhang R, Xie J, Sun Y, Li J. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool? Transfusion 2015;55:395-404. [PMID: 25125223 DOI: 10.1111/trf.12818] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Japhet MO, Adesina OA, Donbraye E, Adewumi MO. Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J 2011;8:513. [PMID: 22074048 DOI: 10.1186/1743-422X-8-513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
7 Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008;48:1001-1026. [PMID: 18454738 DOI: 10.1111/j.1537-2995.2008.01701.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
8 Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58:254-257. [PMID: 20303674 DOI: 10.1016/j.patbio.2010.02.003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 6.9] [Reference Citation Analysis]
9 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
10 Howell DR, Webster MH, Barbara JAJ. Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies. Transfus Med 2000;10:265-9. [DOI: 10.1046/j.1365-3148.2000.00266.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
11 Aguiar JI, Aguiar E, Paniago A, Cunha R, Galvão L, Daher R. Prevalence of antibodies to hepatitis B core antigen in blood donors in the middle West region of Brazil. Mem Inst Oswaldo Cruz 2001;96:185-7. [PMID: 11285495 DOI: 10.1590/s0074-02762001000200009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Makroo RN, Chowdhry M, Bhatia A, Arora B, Rosamma NL. Hepatitis B core antibody testing in Indian blood donors: A double-edged sword! Asian J Transfus Sci. 2012;6:10-13. [PMID: 22623835 DOI: 10.4103/0973-6247.95043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
13 García-Montalvo BM, Farfán-Ale JA, Acosta-Viana KY, Puerto-Manzano FI. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med. 2005;15:371-378. [PMID: 16202051 DOI: 10.1111/j.1365-3148.2005.00610.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
14 Findik D, Arslan U, Baykan M. Determination of hepatitis B virus DNA incidence, viral load, and mutations in blood donors with HBsAg and anti-HBs-negative serology and antibodies to hepatitis B core antigen. Eur J Intern Med. 2007;18:571-575. [PMID: 18054706 DOI: 10.1016/j.ejim.2007.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
15 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Reference Citation Analysis]
16 Molijn MHJ, Linden JM, Ko LK, Gorgels J, Hop W, Rhenen DJ. Risk Factors and Anti-HBc Reactivity among First Time Blood Donors. Vox Sang 1997;72:207-10. [DOI: 10.1046/j.1423-0410.1997.7240207.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lee HH, Allain JP. Genomic screening for blood-borne viruses in transfusion settings. Vox Sang 1998;74 Suppl 2:119-23. [PMID: 9704433 DOI: 10.1111/j.1423-0410.1998.tb05408.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
18 Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 2007;14:16-21. [DOI: 10.1111/j.1365-2893.2007.00912.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
19 Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015;7:600-6. [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
20 Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008;48:2205-2213. [PMID: 18631163 DOI: 10.1111/j.1537-2995.2008.01813.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
21 Lledó JL, Fernández C, Gutiérrez ML, Ocaña S. Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol 2011;17:1563-8. [PMID: 21472122 DOI: 10.3748/wjg.v17.i12.1563] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
22 Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005;45:133-40. [PMID: 15660820 DOI: 10.1111/j.1537-2995.2004.04279.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.0] [Reference Citation Analysis]
23 Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion. 2012;52:440-446. [PMID: 21810101 DOI: 10.1111/j.1537-2995.2011.03283.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
24 Liang RL, Deng QT, Chen ZH, Xu XP, Zhou JW, Liang JY, Dong ZN, Liu TC, Wu YS. Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen. Sci Rep 2017;7:14093. [PMID: 29074971 DOI: 10.1038/s41598-017-14427-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Deng L, Xu Y, Huang J. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody. Comparative Immunology, Microbiology and Infectious Diseases 2008;31:515-26. [DOI: 10.1016/j.cimid.2007.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
26 Gutiérrez C, León G, Loureiro CL, Uzcátegui N, Liprandi F, Pujol FH. Hepatitis B Virus DNA in Blood Samples Positive for Antibodies to Core Antigen and Negative for Surface Antigen. Clin Diagn Lab Immunol 1999;6:768-70. [DOI: 10.1128/cdli.6.5.768-770.1999] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
27 Velati C, Fomiatti L, Baruffi L, Piccinini V, Prati D, Reina A, Lobbiani A, Zanetti A, Romanò L. Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus 2011;9:455-61. [PMID: 21839007 DOI: 10.2450/2011.0014-11] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Alavian SM, Miri SM, Hollinger FB, Jazayeri SM. Occult Hepatitis B (OBH) in Clinical Settings. Hepat Mon 2012;12:e6126. [PMID: 23087749 DOI: 10.5812/hepatmon.6126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
29 Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001;80:63-71. [PMID: 11339072 DOI: 10.1046/j.1423-0410.2001.00003.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 153] [Article Influence: 8.7] [Reference Citation Analysis]
30 Park KW, Chandhok D. Transfusion-Associated Complications: . International Anesthesiology Clinics 2004;42:11-26. [DOI: 10.1097/00004311-200404230-00004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
31 O’Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion. 2007;47:1809-1815. [PMID: 17880605 DOI: 10.1111/j.1537-2995.2007.01396.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
32 Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver International 2009;29:434-42. [DOI: 10.1111/j.1478-3231.2008.01851.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
33 Regan FA, Hewitt P, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group. BMJ 2000;320:403-6. [PMID: 10669443 DOI: 10.1136/bmj.320.7232.403] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
34 Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001;41:652-658. [PMID: 11346702 DOI: 10.1046/j.1537-2995.2001.41050652.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
35 Servant-Delmas A, Chuteau C, Lefort C, Piquet Y, Chevaleyre S, Betbeze V, Delhoume M, Hantz S, Alain S, Laperche S. Two cases of transfusion-transmitted hepatitis B virus (HBV) infection in a low-endemic country before implementation of HBV nucleic acid testing. Transfusion 2013;53:291-6. [PMID: 22671296 DOI: 10.1111/j.1537-2995.2012.03736.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010;17:1-15. [PMID: 20002296 DOI: 10.1111/j.1365-2893.2009.01245.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 9.2] [Reference Citation Analysis]
37 González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion 2010;50:221-30. [PMID: 19682332 DOI: 10.1111/j.1537-2995.2009.02343.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
38 Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity. J Med Virol 2007;79:S32-6. [DOI: 10.1002/jmv.20963] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
39 Stolz M, Tinguely C, Graziani M, Fontana S, Gowland P, Buser A, Michel M, Canellini G, Züger M, Schumacher P, Lelie N, Niederhauser C. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion 2010;50:2695-706. [PMID: 20573074 DOI: 10.1111/j.1537-2995.2010.02732.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
40 Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol. 1999;107:186-195. [PMID: 10520040 DOI: 10.1046/j.1365-2141.1999.01665.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 3.9] [Reference Citation Analysis]
41 Ulrika Noborg, Anki Gusdal, Peter H. Levels of Viraemia in Subjects with Serological Markers of Past or Chronic Hepatitis B Virus Infection. Scandinavian Journal of Infectious Diseases 2009;32:249-52. [DOI: 10.1080/00365540050165866] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
42 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
43 Dindoost P, Jazayeri SM, Karimzadeh H, Saberfar E, Miri SM, Alavian SM. HBsAg Variants: Common Escape Issues. Jundishapur J Microbiol 2012;5:521-7. [DOI: 10.5812/jjm.4243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
44 Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health 2016;110:287-91. [PMID: 27788631 DOI: 10.1080/20477724.2016.1248171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
45 Hughes W, Barr A, Dow BC, Follett EAC, Barbara JAJ. A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfus Med 1995;5:225-30. [DOI: 10.1111/j.1365-3148.1995.tb00232.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009;49:2454-2489. [PMID: 19682345 DOI: 10.1111/j.1537-2995.2009.02322.x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 12.9] [Reference Citation Analysis]
47 Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci. 1997;18:49-53. [PMID: 10174292 DOI: 10.1016/s0955-3886(96)00076-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
48 Inaba S, Ito A, Miyata Y, Ishii H, Kajimoto S, Tanaka M, Maruta A, Saito S, Yugi H, Hino M. Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion. 2006;46:2028-2029. [PMID: 17076860 DOI: 10.1111/j.1537-2995.2006.01011.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
49 Yuen M, Ka-ho Wong D, Lee C, Tanaka Y, Allain J, Fung J, Leung J, Lin C, Sugiyama M, Sugauchi F, Mizokami M, Lai C. Transmissibility of Hepatitis B Virus (HBV) Infection through Blood Transfusion from Blood Donors with Occult HBV Infection. Clinical Infectious Diseases 2011;52:624-32. [DOI: 10.1093/cid/ciq247] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
50 Ozkan S, Atak A, Bozdayi G, Turkcuoglu S, Maral I. Community-based research: cost of the tests used for anti-HBc total seropositivity only and hepatitis B screening. Transactions of the Royal Society of Tropical Medicine and Hygiene 2010;104:782-6. [DOI: 10.1016/j.trstmh.2010.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
51 Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91. [PMID: 15023176 DOI: 10.1111/j.0042-9007.2004.00406.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 11.3] [Reference Citation Analysis]
52 Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol. 2008;48:1022-1025. [PMID: 18436328 DOI: 10.1016/j.jhep.2008.02.016] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 6.3] [Reference Citation Analysis]
53 Liu C, Chen D, Chen P. Epidemiology of HBV infection in Asian blood donors: Emphasis on occult HBV infection and the role of NAT. Journal of Clinical Virology 2006;36:S33-44. [DOI: 10.1016/s1386-6532(06)80007-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
54 Mosley J, Huang W, Stram D, Nowicki M, Hollinger F, Aach R, Stevens C, Barbosa L, Nemo G. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. Transfusion 1996;36:776-81. [DOI: 10.1046/j.1537-2995.1996.36996420752.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
55 Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion. 2002;42:869-875. [PMID: 12375659 DOI: 10.1046/j.1537-2995.2002.00128.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
56 Elghouzzi M, Couroucé A, Magnius L, Lunel F, Lapierre V. Transmission of hepatitis B virus by HBV-negative blood transfusion. The Lancet 1995;346:964. [DOI: 10.1016/s0140-6736(95)91583-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
57 Kupski C, Träsel FR, Mazzoleni F, Winckler MA, Bender AL, Machado DC, Schmitt VM. Serologic and Molecular Profile of Anti-HBc-Positive Blood Bank Donors in an Area of Low Endemicity for HBV. Dig Dis Sci 2008;53:1370-4. [DOI: 10.1007/s10620-007-0019-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
58 Katz L, Strong DM, Tegtmeier G, Stramer S. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Transfusion. 2008;48:2315-2322. [PMID: 18647367 DOI: 10.1111/j.1537-2995.2008.01844.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
59 Allain JP. Genomic screening for blood-borne viruses in transfusion settings. Clin Lab Haematol. 2000;22:1-10. [PMID: 10762297 DOI: 10.1046/j.1365-2257.2000.00265.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
60 Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 2007;47:1794-802. [PMID: 17880603 DOI: 10.1111/j.1537-2995.2007.01394.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
61 Nanu A, Sharma S, Chatterjee K, Jyoti P. Markers for Transfusion-Transmissible Infections in North Indian Voluntary and Replacement Blood Donors: Prevalence and Trends 1989-1996. Vox Sang 1997;73:70-3. [DOI: 10.1046/j.1423-0410.1997.7320070.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
62 Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. J Infect 2005;51:24-9. [PMID: 15979486 DOI: 10.1016/j.jinf.2004.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
63 Allain JP. Epidemiology of Hepatitis B virus and genotype. J Clin Virol. 2006;36 Suppl 1:S12-S17. [PMID: 16831687 DOI: 10.1016/s1386-6532(06)80003-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
64 Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion. 2007;47:74-79. [PMID: 17207233 DOI: 10.1111/j.1537-2995.2007.01066.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
65 Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood. 2002;100:2637-2641. [PMID: 12239179 DOI: 10.1182/blood-2002-03-0798] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 4.2] [Reference Citation Analysis]
66 Gresens CJ, Holland PV. Current risks of viral hepatitis from blood transfusions. J Gastroenterol Hepatol 1998;13:443-9. [PMID: 9641313 DOI: 10.1111/j.1440-1746.1998.tb00663.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
67 Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshøj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L, Ullum H, Candotti D, Lelie N, Gerlich WH, Chudy M. Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion 2013;53:1405-15. [PMID: 23362802 DOI: 10.1111/trf.12096] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 11.0] [Reference Citation Analysis]
68 Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR; SIMTI study group for HBV infection among first-time blood donors. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013;11:281-288. [PMID: 23399361 DOI: 10.2450/2012.0160-12] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
69 Holland P. Post-Transfusion Hepatitis: Current Risks and Causes. Vox Sanguinis 1998;74:135-41. [DOI: 10.1111/j.1423-0410.1998.tb05411.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
70 Bernardin F, Operskalski E, Busch M, Delwart E. Transfusion transmission of highly prevalent commensal human viruses: TRANSFUSION TRANSMISSION OF COMMENSAL VIRUSES. Transfusion 2010;50:2474-83. [DOI: 10.1111/j.1537-2995.2010.02699.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
71 Kumar H, Gupta PK, Jaiprakash M. The Role of anti-HBc IgM in Screening of Blood Donors. Med J Armed Forces India 2007;63:350-2. [PMID: 27408047 DOI: 10.1016/S0377-1237(07)80013-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
72 Jazayeri SM, Alavian SM, Dindoost P, Thomas HC, Karayiannis P. Molecular Variants of Hepatitis B Surface Antigen (HBsAg). In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 107-26. [DOI: 10.1002/9781118637272.ch8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Vermeulen M, van Drimmelen H, Coleman C, Mitchel J, Reddy R, Lelie N. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Transfusion 2014;54:2496-504. [PMID: 24749834 DOI: 10.1111/trf.12657] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
74 Almeida Neto C, Strauss E, Sabino EC, Sucupira MC, Chamone DA. Significance of isolated hepatitis B core antibody in blood donors from São Paulo. Rev Inst Med Trop Sao Paulo 2001;43:203-8. [PMID: 11557999 DOI: 10.1590/s0036-46652001000400005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
75 Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight. Transfusion 2001;41:1081-5. [DOI: 10.1046/j.1537-2995.2001.41091081.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
76 Wei XL, Qiu MZ, Jin Y, Huang YX, Wang RY, Chen WW, Wang DS, Wang F, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases. Br J Cancer 2015;112:1283-90. [PMID: 25695484 DOI: 10.1038/bjc.2014.406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
77 Pereira A. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union. Transfusion 2003;43:192-201. [DOI: 10.1046/j.1537-2995.2003.00280.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
78 Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Nojiri N, Juji T, Hoshino H, Shimoda K, Hino K, Kimura S, Iino S, Koike K. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001;41:1093-1099. [PMID: 11552064 DOI: 10.1046/j.1537-2995.2001.41091093.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 3.1] [Reference Citation Analysis]
79 Khorami F, Sobhani SA, Davoudian P, Khajeh E. Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran. Electron Physician 2013;5:659-63. [PMID: 26120400 DOI: 10.14661/2013.659-663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Busch M. Prevention of Transmission of Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Infections Through Blood Transfusion by Anti-HBc Testing. Vox Sanguinis 1998;74:147-54. [DOI: 10.1111/j.1423-0410.1998.tb05413.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
81 Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata M, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98. [PMID: 26563120 DOI: 10.1007/s12072-015-9675-4] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 949] [Article Influence: 179.3] [Reference Citation Analysis]
82 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
83 Hourfar MK, Walch LA, Geusendam G, Dengler T, Janetzko K, Gubbe K, Frank K, Karl A, Löhr M, Sireis W, Seifried E, Schmidt M. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening? Int J Lab Hematol 2009;31:649-56. [PMID: 18673399 DOI: 10.1111/j.1751-553X.2008.01092.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
84 Christensen PB, Titlestad IL, Homburg KM, Georgsen J, Kristensen T. Hepatitis B core antibodies in Danish blood donors: a surrogate marker of risk behaviour: Hepatitis B core antibodies. Vox Sanguinis 2001;81:222-7. [DOI: 10.1046/j.0042-9007.2001.00113.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
85 Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP; Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003;43:696-704. [PMID: 12757519 DOI: 10.1046/j.1537-2995.2003.00391.x] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 7.3] [Reference Citation Analysis]
86 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 9.6] [Reference Citation Analysis]
87 Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfusion Clinique et Biologique 2004;11:26-32. [DOI: 10.1016/j.tracli.2003.12.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]